Clin2
NCT06731023Possibly a fitNot yet recruiting

14-day treatment for hard-to-cure H. pylori infection

HELICOBACTER PYLORI INFECTIONS

Treatments studied

Part of Digestive system, Infections clinical trials.

This study tests a 14-day treatment plan for people whose H. pylori infection has not been cured by previous treatments. The plan is guided by lab tests to choose the best antibiotics, which may increase the chance of clearing the infection.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years to 70 years
Study type
Observational

Who can take part

  • You are between 18 and 65 years old.
  • You have an active H. pylori infection (confirmed by a breath test or other test).
  • You have already tried at least two standard treatments for H. pylori, and those treatments included at least three antibiotics that are known to have low resistance.
  • You are not pregnant, breastfeeding, or planning to become pregnant during the study.
  • You do not have serious health conditions like liver or kidney failure, a weakened immune system, cancer, or severe heart disease.
  • You have not had stomach or intestinal surgery in the past.
  • You have not taken bismuth, antibiotics, or acid-reducing medications in the last 4 weeks.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07179159Recruiting
14-day stomach infection treatment study

This study compares two treatments for an H. pylori stomach infection: taking two medicines (vonoprazan and amoxicillin) versus taking four medicines. Both treatments are given for 14 days.

Jinan, Shandong
NCT06723197Recruiting· Phase 4
Comparing treatment lengths for H. pylori infection

This trial compares different lengths of treatment with two or four medications to see which works best for clearing H. pylori, a stomach bacteria that can cause ulcers. It is for people who have not been treated for this infection before.

Jinan, Shandong
NCT07142798Enrolling by invitation
14-day triple therapy for H. pylori infection

This trial tests a 14-day treatment using bismuth, amoxicillin, and a stomach acid reducer (PCAB) to see how well it clears H. pylori, a bacteria that can cause stomach ulcers. It may be an option if you have H. pylori and haven't had stomach surgery or certain serious health conditions.

Kaohsiung City
NCT07757919Not yet recruiting· Phase 4
14-day treatment for H. pylori infection

This trial tests a 14-day course of two medicines, vonoprazan and minocycline, to see how well they clear an H. pylori stomach infection. If you have H. pylori and haven't been treated for it before, this study may help you get rid of the infection.

NCT07405684Not yet recruiting· Phase 4
Stool-guided treatment for first-time H. pylori infection

This study compares different first-line antibiotic treatments for H. pylori, a stomach infection that can cause ulcers and other issues. It uses a stool test to choose the best treatment for each person, aiming to improve cure rates and reduce antibiotic resistance.

Shanghai, Shanghai Municipality
NCT07576959Recruiting· Phase 3
Bismuth with dual therapy for H. pylori infection treatment

This trial tests whether adding bismuth (a mineral compound) to standard two-drug therapy helps cure H. pylori, a common stomach bacteria that can cause ulcers and inflammation. The goal is to see if this combination works better than dual therapy alone.

Taipei

Hear when a new HELICOBACTER PYLORI INFECTIONS trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.